Contraceptive Drugs Market Report by Product (Oral Contraceptive Pills, Injectable Contraceptives, Topical Contraceptives), Age Group (15–24 years, 25–34 years, 35–44 years, Above 44 years), Distribution Channel (Retail Pharmacy, Hospital Pharmacy, Clinic

Contraceptive Drugs Market Report by Product (Oral Contraceptive Pills, Injectable Contraceptives, Topical Contraceptives), Age Group (15–24 years, 25–34 years, 35–44 years, Above 44 years), Distribution Channel (Retail Pharmacy, Hospital Pharmacy, Clinics, Online Channel, Public Channel and NGOs, and Others), and Region 2024-2032

The global contraceptive drugs market size reached US$ 15.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 24.5 Billion by 2032, exhibiting a growth rate (CAGR) of 4.9% during 2024-2032.

Contraceptive drugs refer to birth control medications that are used to prevent pregnancy and control the birth rate. They are synthetically formulated using two female hormones, namely estrogen and progestin, which prevent ovulation. These hormones also thicken cervical mucus or alter the womb lining to prohibit the entrance of sperm into the cervix for fertilization and implantation. Contraceptive drugs assist in lowering the risks of acne, bone thinning, ovarian cancer, infections in the fallopian tubes and uterus, and premenstrual syndrome (PMS). As a result, they are administered by healthcare practitioners to inhibit unwanted pregnancy amongst women of childbearing age. At present, they are mainly available in oral, injectable, and topical formulations.

Contraceptive Drugs Market Trends:
One of the key factors driving the global contraceptive drugs market is the rising consumer consciousness regarding family planning, the increasing population, and the rising instances of unintended pregnancies. In line with this, the shifting inclination of healthcare practitioners toward modern contraceptive methods over conventional procedures, owing to their multiple benefits, including optimal safety, and better clinical outcomes, are acting as another growth-inducing factor. Additionally, the frequent approvals of novel medications by several regulatory bodies, such as the food and drug administration (FDA), are supporting the market growth. Moreover, the advent of gelatin capsules and non-hormonal vaginal gels that create an inhospitable environment for sperm to sustain by maintaining vagina pH levels is impelling the market growth. Apart from this, continuous research and development (R&D) activities and the favorable initiatives undertaken by non-governmental organizations (NGOs) and health agencies to sensitize consumers about contraception techniques, women’s health, and sexual wellness are positively augmenting the market growth.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global contraceptive drugs market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, age group and distribution channel.

Breakup by Product:

Oral Contraceptive Pills
Injectable Contraceptives
Topical Contraceptives

Breakup by Age Group:

15–24 years
25–34 years
35–44 years
Above 44 years

Breakup by Distribution Channel:

Retail Pharmacy
Hospital Pharmacy
Clinics
Online Channel
Public Channel and NGOs
Others

Breakup by Region:

North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being AbbVie Inc., Afaxys Inc., Agile Therapeutics, Amneal Pharmaceuticals Inc., Bayer AG, Johnson & Johnson, Mithra Pharmaceuticals SA, Novartis AG, Pfizer Inc., Teva Pharmaceutical Industries Ltd. and Viatris Inc.

Key Questions Answered in This Report

1. What was the size of the global contraceptive drugs market in 2023?
2. What is the expected growth rate of the global contraceptive drugs market during 2024-2032?
3. What are the key factors driving the global contraceptive drugs market?
4. What has been the impact of COVID-19 on the global contraceptive drugs market?
5. What is the breakup of the global contraceptive drugs market based on the product?
6. What is the breakup of the global contraceptive drugs market based on the age group?
7. What is the breakup of the global contraceptive drugs market based on the distribution channel?
8. What are the key regions in the global contraceptive drugs market?
9. Who are the key players/companies in the global contraceptive drugs market?